Doctor of Philosophy The University of Adelaide
Bachelor of Science The University of Adelaide
Diploma of Pharmacy The University of Adelaide
Excludes commercial-in-confidence projects.
Research outputs for the last seven years are shown below.
Open access indicates that an output is open access.
Howe, K, Bourke, S & Sansom, L 2021, 'The extent to which off-patent registered prescription medicines are used for off-label indications in Australia: a scoping review', PLoS One, vol. 16, no. 12, article no. e0261022, pp. 1-17.
Open access 1 1
Latimer, NR, Pollard, D, Towse, A, Henshall, C, Sansom, L, Ward, RL, Bruce, A & Deakin, C 2021, 'Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi‐stakeholder, international workshop', BMC Health Services Research, vol. 21, no. 1, article no. 412, pp. 1-9.
Open access 6 4 2
Wale, J, Scott, AM, Hofmann, B, Garner, S, Low, E & Sansom, L 2017, 'Why patients should be involved in health technology assessment', International Journal of Technology Assessment in Health Care, vol. 33, no. 1, pp. 1-4.
Open access 27 23 39
Henshall, C, Latimer, NR, Sansom, LN & Ward, RL 2016, 'Treatment switching in cancer trials: Issues and proposals', International Journal of Technology Assessment in Health Care, vol. 32, no. 3, pp. 167-174.
Open access 16 16 1
Henshall, C, Sansom, LN, Eichler, H-G, Lembruger, A, Longson, C, O'Rourke, B & Tunis, S 2014, 'Understanding the role and evidence expectations of health technology assessment and coverage/payer bodies: What are they looking for, and how and why does this differ from what regulators require?', Therapeutic Innovation and Regulatory Science, vol. 48, no. 3, pp. 341-346.
7 7 10
Juhasz, AL, Smith, ERG, Weber, J, Rees, M, Kuchel, T, Rofe, A, Sansom, LN & Naidu, R 2013, 'Predicting lead relative bioavailability in peri-urban contaminated soils using in vitro bioaccessibility assays', Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering, vol. 48, no. 6, pp. 604-611.
31 29 1
Sansom, LN 2010, 'Assessing the value of medicines', Pharmaceutical Medicine, vol. 24, no. 2, pp. 89-92.
Juhasz, AL, Weber, J, Smith, E, Naidu, R, Marschner, B, Rees, M, Rofe, A, Kuchel, T & Sansom, L 2009, 'Evaluation of SBRC-Gastric and SBRC-Intestinal methods for the prediction of in vivo relative lead bioavailability in contaminated soils', Environmental Science and Technology, vol. 43, no. 12, pp. 4503-4509.
Juhasz, AL, Weber, J, Smith, E, Naidu, R, Rees, M, Rofe, A, Kuchel, T & Sansom, L 2009, 'Assessment of four commonly employed in vitro arsenic bioaccessibility assays for predicting in vivo relative arsenic bioavailability in contaminated soils', Environmental Science and Technology, vol. 43, no. 24, pp. 9487-9494.
Rahman, MM, Rahman, F, Sansom, L, Naidu, R & Schmidt, O 2009, 'Arsenic interactions with lipid particles containing iron', Environmental Geochemistry and Health: Official Journal of the Society for Environmental Geochemistry and Health, vol. 31, no. s1, pp. 201-206.
Rees, M, Sansom, L, Rofe, A, Juhasz, AL, Smith, E, Weber, J, Naidu, R & Kuchel, T 2009, 'Principles and application of an in vivo swine assay for the determination of arsenic bioavailability in contaminated matrices', Environmental Geochemistry and Health: Official Journal of the Society for Environmental Geochemistry and Health, vol. 31, s1, pp. 167-177.
Juhasz, AL, Smith, ERG, Weber, J, Naidu, R, Rees, M, Rofe, A, Kuchel, T & Sansom, LN 2008, 'Application of an In Vivo Swine Model for the Determination of Arsenic Bioavailability in Hydroponically-Grown Vegetables', Chemosphere, vol. 71, no. 10, pp. 1963-1969.
Juhasz, AL, Smith, ERG, Weber, J, Naidu, R, Rees, M, Rofe, A, Kuchel, T & Sansom, LN 2008, 'Effect of Soil Ageing on In Vivo Arsenic Bioavailability in Two Dissimilar Soils', Chemosphere, vol. 71, no. 11, pp. 2180-2186.
|Australian National University||AUSTRALIA|
|Brunel University||UNITED KINGDOM|
|Brunel University London||UNITED KINGDOM|
|Canadian Agency for Drugs and Technologies in Health||CANADA|
|Center for Medical Technology Policy||UNITED STATES|
|European Medicines Agency||NETHERLANDS|
|Health Technology Assessment International (HTAi)||CANADA|
|Institute of Medical and Veterinary Science||AUSTRALIA|
|Myeloma UK||UNITED KINGDOM|
|National Institute for Health and Care Excellence||UNITED KINGDOM|
|National Institute for Health and Care Excellence (NICE)||UNITED STATES|
|Office of Health Economics||UNITED KINGDOM|
|Pan American Health Organization||CUBA|
|Ruhr University Bochum||GERMANY|
|South Australian Health and Medical Research Institute (SAHMRI)||AUSTRALIA|
|University of Adelaide||AUSTRALIA|
|University of Oslo||NORWAY|
|University of Queensland||AUSTRALIA|
|University of Sheffield||UNITED KINGDOM|
|University of South Australia||AUSTRALIA|
|University of Sydney||AUSTRALIA|
Andre Bedat Award
International Pharmaceutical Association